John Owen Brennan Immunity Bio, Inc. (IBRX) insider trading activity
John Owen Brennan is Director of ImmunityBio, Inc.. Currently has a direct ownership of 25,000 shares of IBRX, which is worth approximately $130,000. The most recent transaction as insider was on Jun 02, 2023, when has been sold 25,000 shares (Common Stock) at a price of $2.81 per share, resulting in proceeds of $70,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25K
0%
3M change
0%
12M change
Total Value Held
$130,000
JOB
John Owen Brennan
Director
San Diego, CA